pubmed-article:10103339 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10103339 | lifeskim:mentions | umls-concept:C0019693 | lld:lifeskim |
pubmed-article:10103339 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
pubmed-article:10103339 | lifeskim:mentions | umls-concept:C0871489 | lld:lifeskim |
pubmed-article:10103339 | lifeskim:mentions | umls-concept:C0021270 | lld:lifeskim |
pubmed-article:10103339 | lifeskim:mentions | umls-concept:C0599685 | lld:lifeskim |
pubmed-article:10103339 | lifeskim:mentions | umls-concept:C0663655 | lld:lifeskim |
pubmed-article:10103339 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
pubmed-article:10103339 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:10103339 | lifeskim:mentions | umls-concept:C0540137 | lld:lifeskim |
pubmed-article:10103339 | lifeskim:mentions | umls-concept:C1318970 | lld:lifeskim |
pubmed-article:10103339 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:10103339 | pubmed:dateCreated | 1999-4-15 | lld:pubmed |
pubmed-article:10103339 | pubmed:abstractText | To evaluate the pharmacokinetic features, safety, and tolerance of abacavir, given alone and in combination with other nucleoside antiretroviral agents, in symptomatic human immunodeficiency virus (HIV)-infected children. | lld:pubmed |
pubmed-article:10103339 | pubmed:language | eng | lld:pubmed |
pubmed-article:10103339 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10103339 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10103339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10103339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10103339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10103339 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10103339 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10103339 | pubmed:month | Apr | lld:pubmed |
pubmed-article:10103339 | pubmed:issn | 1098-4275 | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:BlanchardSS | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:FletcherC VCV | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:KovacsAA | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:DanknerW MWM | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:McDowellJ AJA | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:McKinneyR... | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:KlineM WMW | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:BrundageR CRC | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:Van DykeR BRB | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:ShenepJ LJL | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:HetheringtonS... | lld:pubmed |
pubmed-article:10103339 | pubmed:author | pubmed-author:CulnaneMM | lld:pubmed |
pubmed-article:10103339 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:10103339 | pubmed:volume | 103 | lld:pubmed |
pubmed-article:10103339 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10103339 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10103339 | pubmed:pagination | e47 | lld:pubmed |
pubmed-article:10103339 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:meshHeading | pubmed-meshheading:10103339... | lld:pubmed |
pubmed-article:10103339 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10103339 | pubmed:articleTitle | A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team. | lld:pubmed |
pubmed-article:10103339 | pubmed:affiliation | Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas 77030, USA. | lld:pubmed |
pubmed-article:10103339 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10103339 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10103339 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:10103339 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:10103339 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:10103339 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10103339 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10103339 | lld:pubmed |